Chin Wen
- Co-authors
- Chew Wun WuAnna F.-Y. LiWen‐chang LinShih‐Hsuan ChanLiang‐Ming LeeChin‐Chen PanChi‐Ying F. HuangA.-P. Tsou
- Topics
- Cancer, Hypoxia, and Metabolism (2 papers)Inflammatory mediators and NSAID effects (2 papers)Cancer-related molecular mechanisms research (2 papers)
In The Last Decade
Chin Wen
17 papers receiving 611 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 343
- Cancer Research 317
- Oncology 119
- Genetics 72
- Pharmacology 68
Countries citing papers authored by Chin Wen
This map shows the geographic impact of Chin Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin Wen more than expected).
Fields of papers citing papers by Chin Wen
This network shows the impact of papers produced by Chin Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin Wen. The network helps show where Chin Wen may publish in the future.
Co-authorship network of co-authors of Chin Wen
This figure shows the co-authorship network connecting the top 25 collaborators of Chin Wen. A scholar is included among the top collaborators of Chin Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin Wen. Chin Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Anticolorectal cancer effects and pharmacokinetic application of 2, 2-Bis [4-(4-amino-3-hydroxyphenoxy) phenyl] adamantane. | 1 |
| 2 | 48 | |
| 3 | 5 | |
| 4 | Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA). | 5 |
| 5 | 54 | |
| 6 | Mitochondrial stress-induced genes and pathways changes in human hepatoma cells | 2 |
| 7 | miR-21 microRNA expression in human gastric carcinomas and its clinical association. | 177 |
| 8 | Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter. | 14 |
| 9 | High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis. | 11 |
| 10 | PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. | 14 |
| 11 | 124 | |
| 12 | Arg tyrosine kinase expression in human gastric adenocarcinoma is associated with vessel invasion. | 10 |
| 13 | Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. | 83 |
| 14 | Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer. | 16 |
| 15 | Serum tumor necrosis factor in patients with gastric cancer. | 12 |
| 16 | 21 | |
| 17 | 30 |
About Chin Wen
Chin Wen is a scholar working on Cancer Research, Oncology and Pharmacology, having authored 17 papers that have together received 627 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (317 citations), Molecular Biology (343 citations) and Oncology (119 citations). Chin Wen has collaborated with scholars based in Taiwan and Czechia. Frequent co-authors include Chew Wun Wu, Anna F.-Y. Li, Wen‐chang Lin, Shih‐Hsuan Chan, Liang‐Ming Lee, Chin‐Chen Pan, Chi‐Ying F. Huang, A.-P. Tsou, Yu‐Fang Chung and A. C. Jermy. Their work appears in journals such as Oncogene, International Journal of Radiation Oncology*Biology*Physics and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.